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a  b  s  t  r  a  c  t
A  case  of  acute  Wernicke’s  encephalopathy  induced  by thiamine  deﬁciency  due  to  malnutrition  sub-
sequent  to chemoradiotherapy  for  tongue  cancer  is  presented.  A  63-year-old  male  patient  had  severe
oral  mucositis  and  mental  stress  in  a  long-term  hospitalization  for  chemoradiotherapy  of tongue  cancer.ccepted 29 March 2013
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After  discharge  from  hospital,  he  had  alcoholism  and  malnutrition.  Three  months  later,  disturbance  of
consciousness  and  ataxia  followed  by  memory  disturbance  appeared.  Laboratory  examination  revealed
low  serum  level  of thiamine.  The  symptoms,  laboratory  data,  and  magnetic  resonance  imaging  suggested
acute  Wernicke’s  encephalopathy.  The  patient  was  intravenously  administered  thiamine  and  received
nutritional  control,  thereby  the  symptoms  were  improved.
© 2013 Published by Elsevier Ltd on behalf of Japanese Stomatological Society.. Introduction
Wernicke’s encephalopathy, a thiamine deﬁciency disorder, is a
eurological emergency and can be fatal if untreated. It occurs com-
only associated with alcoholism and is characterized by changes
n consciousness, ocular dysfunction, and ataxia [1]. Thiamine, also
nown as vitamin B1, is an essential nutrient required by all tis-
ues. Thiamine deﬁciency can lead to death. The mortality rate is
eported 17–20%, and 85% of survivors developed Korsakoff’s psy-
hosis characterized by short-term memory disorder [2].
Oral  mucositis is a signiﬁcant problem for cancer patients receiv-
ng high-dose head and neck radiation therapy and occurs at the
requency of 85–100% [3]. We  report a case of a tongue cancer
atient showing acute Wernicke’s encephalopathy due to severe
ral mucositis induced by chemoradiotherapy and successfully
reated by intravenous thiamine therapy.
. Case report
A 63-year-old male was referred to our clinic with a chief
omplaint of ulcer formation which had induration measuring
2 mm  × 25 mm of the left tongue margin. The left submandi-
ular lymph node showed increased ﬂuorodeoxyglucose uptake
n positron emission tomography. On biopsy, the lesion was  diag-
osed as a tongue squamous cell carcinoma (T3N1M0). As the
atient strongly hoped for conservative therapies, we  performed a
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ttp://dx.doi.org/10.1016/S1348-8643(13)00007-4superselective intra-arterial chemotherapy by the Seldinger tech-
nique (cisplatin 50 mg/bolus/week for 4 weeks) and concurrent
radiotherapy (total dose: 60 Gy). After chemoradiotherapy, the pri-
mary tumor and metastatic lymph node had regressed, although
severe oral mucositis remained. The patient suffered from mental
stress after long-term hospitalization for chemoradiotherapy and
hoped to be discharged from our hospital as soon as he ﬁnished his
chemoradiotherapy course. After that, he had little food because of
painful oral mucositis and ageusia induced by chemoradiotherapy.
He unavoidably depended on alcohol and had an unbalanced diet.
After three months, his family noticed his memory disorder. Neuro-
logically, disturbance of consciousness, confusion, and ataxia were
recognized, and ophthalmoplegia was slightly shown. The patient
had vacant eyes and his eyes did not respond to surrounding move-
ment. Laboratory examination showed almost normal ranges; a red
blood cell count of 3.83 × 106l−1, a hemoglobin level of 13.3 g/dl,
a white blood cell count of 3260 l−1, and a platelet count of
14.8 × 104l−1. A serum liver chemistry proﬁle showed aspartate
aminotransaminase 152 U/l, and alanine aminotransferase 78 U/l,
and the level of total protein was at 8.0 g/dl. However, thiamine
level was  at 10 ng/ml, lower than normal range (20–50 ng/ml). Mag-
netic resonance imaging (MRI) showed a periaqueductal high signal
intensity area in T2WI, but did not show primary tumor recur-
rence, lymph node metastasis, metastasis to the brain, or atrophy
of hippocampus (Fig. 1). Positron emission tomography-computed
tomography did not show any abnormality in his whole body. He
was  diagnosed with Wernicke’s encephalopathy by these symp-
toms and imaging ﬁndings. Immediately we  conducted nutritional
control and administered thiamine (100 mg)  intravenously under
hospitalization for two weeks. After recovery of thiamine level
omatological Society.
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[ig. 1. Magnetic resonance imaging ﬁnding. Axial T2-weighted image shows a peri-
queductal high signal intensity area (arrow).
66 ng/ml after 2 weeks), the symptoms were rapidly improved.
owever, he lost the memory of some months before thiamine
reatment, and the forgotten memory remained lost. Unfortunately,
his event triggered the retirement from his job.
.  Discussion
Wernicke’s encephalopathy is most commonly observed in
eople with alcoholism. Alcoholism interferes with absorption of
utrients including thiamine from the digestive system [4]. There-
ore, more thiamine is needed than the ordinary level in patients
ith alcoholism. The traditional triad of this disease is confusion,
taxia, and ophthalmoplegia, but the symptoms are often absent in
lcoholic and non-alcoholic cases [5–7]. According to the criteria of
aine et al. [8], Wernicke’s encephalopathy can be diagnosed by any
wo of eye signs, cerebellar dysfunction, altered mental state, and
ietary deﬁciencies. In our patient, we found eye signs and altered
ental state. Although a periaqueductal high signal area on the
RI was not typical [9], it may  be due to the time when MRI  was
aken. In addition, the memory disorder of two months seen before
hiamine treatment suggested that progression to Korsakoff’s psy-
hosis occurred [10]. When thiamine deﬁciency is suggested in
 patient, we should treat him immediately without waiting for
he laboratory data of thiamine level. Recommended treatment is
[
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administration of 500 mg  thiamine intravenously for 2–3 days and
250 mg  daily for the next 3–5 days [11].
Thiamine deﬁciency has rarely been described recently in
patients with head and neck cancer. Cho et al. [12] and Aksoy
et al. [13] reported Wernicke’s encephalopathy in patients receiv-
ing ﬂuorouracil-based chemotherapy for nasopharyngeal cancer.
Fikhman et al. [14] reported two  cases in a patient receiving post-
operative chemoradiotherapy for tongue cancer and in a patient
receiving primary chemoradiotherapy for tonsil cancer.
Radiotherapy for oral cancer almost always causes severe oral
mucositis or loss of appetite, therefore the risk of low nutrition is
very high. In particular, we  must pay attention to the aged who
live at home alone receiving terminal cancer therapy, because they
are unable to manage nutrition on their own. We also have to take
into account the social background of our cancer patients as well
as their local lesions and courses of their therapy. In the follow-up
of the patient after treatment for oral cancer, we should check not
only malnutrition but also thiamine level in laboratory tests, if we
noticed symptoms suspected of Wernicke’s encephalopathy.
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